DnB Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Buy
213,259
+160,089
+301% +$19.4M 0.06% 197
2026
Q1
$8.69M Buy
53,170
+12,252
+30% +$1.88M 0.03% 329
2025
Q4
$7.12M Buy
40,918
+37,522
+1,105% +$6.85M 0.02% 362
2025
Q3
$489K Buy
3,396
+1,334
+65% +$163K ﹤0.01% 674
2025
Q2
$208K Buy
+2,062
New +$158K ﹤0.01% 698

Other funds holding INSM

DnB Asset Management's INSM Position: Q2 2026 in Review

DnB Asset Management increased its Insmed (INSM) stake by 301% in Q2 2026, buying an estimated $19.4M and bringing the position to 213,259 shares worth $22.7M. The position accounts for 0.06% of the portfolio, ranked #197.

DnB Asset Management first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. 332 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • DnB Asset Management held 213,259 shares of Insmed worth $22.7M as of Q2 2026.
  • DnB Asset Management bought 160,089 Insmed shares in Q2 2026, an estimated $19.4M.
  • Insmed made up 0.06% of DnB Asset Management's portfolio in Q2 2026, its #197 holding.
  • DnB Asset Management first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • 332 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.